Ozempic vs Mounjaro in 2026: Which GLP-1 Is Right for You?
Introduction Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. The choice between GLP-1 medications requires individualized assessment by a qualified healthcare provider. The two heavyweight champions of GLP-1 weight loss — Ozempic (semaglutide) and Mounjaro (tirzepatide) — dominate the conversation in 2026. But the weight loss injectables landscape now includes several options: liraglutide (Saxenda, an older daily GLP-1), semaglutide (Ozempic/Wegovy, weekly), and tirzepatide (Mounjaro/Zepbound, weekly dual-agonist). Which one should you choose? ...